Hello and welcome to the HSP90 inhibitors Central website!
On this site, you will find the most comprehensive collection of information about drugs in development that target the key cellular chaperone protein known as heat shock protein 90, or HSP90 for short.
These drugs are emerging as a potentially valuable new class of cancer treatments, and as such may offer attractive investment opportunities. However, the history of drugs targeting this protein continues to be littered with abandoned drugs saddled with unacceptable toxicity. Therefore, carefully navigating the preclinical and early clinical data is essential to determining which drugs may become commercially viable.
Also be sure to visit my sister site "BiotechDueDiligence" where, along with a great deal of biotech stock research, info, and resources, you can already find detailed discussion of HSP90 inhibitors in development from companies such as Synta Pharma $SNTA, Astex Pharma $ASTX (recently merged with Supergen $SUPG), Myrexis $MYRX, and Infinity Pharma $INFI.
Questions, comments, or feedback? Use the form below.
If you find this free website helpful, please consider making a donation.
These drugs are emerging as a potentially valuable new class of cancer treatments, and as such may offer attractive investment opportunities. However, the history of drugs targeting this protein continues to be littered with abandoned drugs saddled with unacceptable toxicity. Therefore, carefully navigating the preclinical and early clinical data is essential to determining which drugs may become commercially viable.
Also be sure to visit my sister site "BiotechDueDiligence" where, along with a great deal of biotech stock research, info, and resources, you can already find detailed discussion of HSP90 inhibitors in development from companies such as Synta Pharma $SNTA, Astex Pharma $ASTX (recently merged with Supergen $SUPG), Myrexis $MYRX, and Infinity Pharma $INFI.
Questions, comments, or feedback? Use the form below.
If you find this free website helpful, please consider making a donation.
|
|
|
What's New in HSP90 Clinical Trials |
|
